If I remember correctly the principal investigator recommended a patient in cohort 1 be moved to cohort 2 as they were doing so well.
Effectively , that person went 1 - 2 - 4.
So this individual got double counted in the intake of 1 and 2 ( ie. only ever 12 people, but was in the initial date for 1 & 2, but finished in cohort 2 only ).
Clear as mud !
I think that is the way it went down.
Ann: Appendix 4C & Quarterly Update, page-50
Add NUZ (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
20.0¢ |
Change
0.015(8.11%) |
Mkt cap ! $98.34M | |||
| Open | High | Low | Value | Volume |
| 19.0¢ | 20.0¢ | 19.0¢ | $66.44K | 346.2K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 86359 | 19.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 20.0¢ | 107894 | 5 |
View Market Depth
| Last trade - 15.42pm 13/11/2024 (20 minute delay) ? |
| NUZ (ASX) Chart |